Azaindoles as Zinc‐Binding Small‐Molecule Inhibitors of the JAMM Protease CSN5. Issue 5 (16th December 2016)

• Record Type: Journal Article
• Authors: Altmann, Eva; Erbel, Paul; Renatus, Martin; Schaefer, Michael; Schlierf, Anita; Druet, Adelaide; Kieffer, Laurence; Sorge, Mickael; Pfister, Keith; Hassiepen, Ulrich; Jones, Matthew; Ruedisser, Simon; Ostermeier, Daniela; Martoglio, Bruno; Jefferson, Anne B.; Quancard, Jean
• Is Part Of: Angewandte Chemie international edition. Volume 56:Issue 5(2017)
• Page Start: 1294
• Page End: 1297
• Publication Date: 2016-12-16
• Subjects: azaindoles -- CSN5 -- ubiquitin ligases -- inhibitors -- metalloproteases; Chemistry -- Periodicals; 540
• DOI: 10.1002/anie.201608672
• Languages: English
• ISSNs: 1433-7851

Abstract

Abstract: CSN5 is the zinc metalloprotease subunit of the COP9 signalosome (CSN), which is an important regulator of cullin‐RING E3 ubiquitin ligases (CRLs). CSN5 is responsible for the cleavage of NEDD8 from CRLs, and blocking deconjugation of NEDD8 traps the CRLs in a hyperactive state, thereby leading to auto‐ubiquitination and ultimately degradation of the substrate recognition subunits. Herein, we describe the discovery of azaindoles as a new class of CSN5 inhibitors, which interact with the active‐site zinc ion of CSN5 through an unprecedented binding mode. The best compounds inhibited CSN5 with nanomolar potency, led to degradation of the substrate recognition subunit Skp2 in cells, and reduced the viability of HCT116 cells. Abstract : CSN5 is the zinc metalloprotease subunit of the COP9 signalosome, which is an important regulator of cullin‐RING E3 ubiquitin ligases. A new class of CSN5 inhibitors (orange) was discovered and shown to interact with the active‐site zinc ion in an unprecedented binding mode. Optimized nanomolar CSN5 inhibitors result in decreased levels of the oncoprotein Skp2 and reduce the viability of HCT116 cells.